Diabetes and COVID-19 : Considerations and Clinical Management

Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them.

Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology,infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.